These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 27982090

  • 21. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
    Huang Z, Elankumaran S, Yunus AS, Samal SK.
    J Virol; 2004 Sep; 78(18):10054-63. PubMed ID: 15331738
    [Abstract] [Full Text] [Related]

  • 22. Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Andoh K, Yamazaki K, Honda Y, Honda T.
    Arch Virol; 2017 Apr; 162(4):931-941. PubMed ID: 27942974
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM, Cortes AL, Faiz NM, Hernandez-Ortiz BA, Guy JS, Hunt HD, Silva RF.
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L, Su S, Wang Y, Li S, Sun P, Chen W, Cui Z.
    Wei Sheng Wu Xue Bao; 2014 Nov 04; 54(11):1353-61. PubMed ID: 25752142
    [Abstract] [Full Text] [Related]

  • 26. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection.
    Xu XG, Tong DW, Wang ZS, Zhang Q, Li ZC, Zhang K, Li W, Liu HJ.
    Avian Dis; 2011 Jun 04; 55(2):223-9. PubMed ID: 21793437
    [Abstract] [Full Text] [Related]

  • 27. Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine.
    Kurukulasuriya S, Ahmed KA, Ojkic D, Gunawardana T, Goonewardene K, Gupta A, Chow-Lockerbie B, Popowich S, Willson P, Tikoo SK, Gomis S.
    Vaccine; 2017 Feb 07; 35(6):882-888. PubMed ID: 28089549
    [Abstract] [Full Text] [Related]

  • 28. Virus-Induced Immunosuppression in Chickens.
    Gimeno IM, Schat KA.
    Avian Dis; 2018 Sep 07; 62(3):272-285. PubMed ID: 30339511
    [Abstract] [Full Text] [Related]

  • 29. A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain.
    Cui X, Lee LF, Hunt HD, Reed WM, Lupiani B, Reddy SM.
    Avian Dis; 2005 Jun 07; 49(2):199-206. PubMed ID: 16094823
    [Abstract] [Full Text] [Related]

  • 30. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
    Sonoda K, Sakaguchi M, Okamura H, Yokogawa K, Tokunaga E, Tokiyoshi S, Kawaguchi Y, Hirai K.
    J Virol; 2000 Apr 07; 74(7):3217-26. PubMed ID: 10708438
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV.
    Wang YS, Ouyang W, Liu XJ, He KW, Yu SQ, Zhang HB, Fan HJ, Lu CP.
    Vaccine; 2012 Mar 09; 30(12):2125-30. PubMed ID: 22285269
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W, Song Y, Liu L, Zhang Y, Wang T, Zhang W, Li K, Qi X, Gao Y, Gao L, Liu C, Zhang Y, Wang Y, Pan Q, He G, Wang X, Cui H.
    Microb Cell Fact; 2019 Jan 31; 18(1):21. PubMed ID: 30704494
    [Abstract] [Full Text] [Related]

  • 35. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S, Sun W, Chu J, Huang X, Wu Z, Yan M, Zhang Q, Zhao P, Igietseme JU, Black CM, He C, Li Y.
    PLoS One; 2015 Jan 31; 10(4):e0124992. PubMed ID: 25893439
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
    Lee LF, Cui X, Cui Z, Gimeno I, Lupiani B, Reddy SM.
    Virus Genes; 2005 Aug 31; 31(1):73-80. PubMed ID: 15965611
    [Abstract] [Full Text] [Related]

  • 40. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
    Rong J, Jiang T, Cheng T, Shen M, Du Y, Li S, Wang S, Xu B, Fan G.
    Vaccine; 2007 Nov 14; 25(46):7900-8. PubMed ID: 17923174
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.